Alder BioPharmaceuticals' Series B Round

Alder BioPharmaceuticals raised a round of funding on July 24, 2006.

Alder BioPharmaceuticals identifies, develops and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas. The com…

Articles about Alder BioPharmaceuticals' Series B Round: